Elevated secondary infection rates in patients with coronavirus disease 2019 (COVID-19) requiring extracorporeal membrane oxygenation

Infect Control Hosp Epidemiol. 2021 Jun;42(6):770-772. doi: 10.1017/ice.2021.61. Epub 2021 Feb 9.
No abstract available

MeSH terms

  • Adult
  • COVID-19 / complications
  • COVID-19 / therapy*
  • Cross Infection / epidemiology
  • Cross Infection / etiology*
  • Extracorporeal Membrane Oxygenation / adverse effects*
  • Female
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use
  • Influenza, Human / complications
  • Influenza, Human / therapy
  • Male
  • Middle Aged
  • Retrospective Studies
  • Texas / epidemiology

Substances

  • Immunosuppressive Agents